
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Can Soluble Immune Checkpoint Molecules on Exosomes Mediate Inflammation?
Julie Joseph, Benjamin Rahmani, Yonesha Cole, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 17, Iss. 3-4, pp. 381-397
Open Access | Times Cited: 11
Julie Joseph, Benjamin Rahmani, Yonesha Cole, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 17, Iss. 3-4, pp. 381-397
Open Access | Times Cited: 11
Showing 11 citing articles:
Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies
Stephanie Pitts, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Stephanie Pitts, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art
Hamid Heydari Sheikh Hossein, Francesca Iommelli, Natalia Di Pietro, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 519-519
Open Access | Times Cited: 5
Hamid Heydari Sheikh Hossein, Francesca Iommelli, Natalia Di Pietro, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 519-519
Open Access | Times Cited: 5
Soluble immune checkpoints are dysregulated in patients with sickle cell disease and correlate with inflammatory mediators, autoantibodies, immune cell profiles, and clinical outcomes
W. Li, Andrew Q Pucka, Lina Houran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
W. Li, Andrew Q Pucka, Lina Houran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Exosome-Like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art
Hamid Heydari Sheikhhossein, Francesca Iommelli, Natalia Di Pietro, et al.
(2024)
Open Access | Times Cited: 3
Hamid Heydari Sheikhhossein, Francesca Iommelli, Natalia Di Pietro, et al.
(2024)
Open Access | Times Cited: 3
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 2
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 2
Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
Nuri Lee, Seri Jeong, Kibum Jeon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Nuri Lee, Seri Jeong, Kibum Jeon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Retroviral b‐Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation
Julie Joseph, Thomas A. Premeaux, Daniel O. Pinto, et al.
Journal of Extracellular Biology (2023) Vol. 2, Iss. 7
Open Access | Times Cited: 5
Julie Joseph, Thomas A. Premeaux, Daniel O. Pinto, et al.
Journal of Extracellular Biology (2023) Vol. 2, Iss. 7
Open Access | Times Cited: 5
Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
O. Bar, Angel Porgador, Tomer Cooks
Journal of Extracellular Biology (2024) Vol. 3, Iss. 9
Open Access | Times Cited: 1
O. Bar, Angel Porgador, Tomer Cooks
Journal of Extracellular Biology (2024) Vol. 3, Iss. 9
Open Access | Times Cited: 1
Predicting survival in patients with SARS-CoV-2 based on cytokines and soluble immune checkpoint regulators
Nuri Lee, Kibum Jeon, Min-Jeong Park, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Nuri Lee, Kibum Jeon, Min-Jeong Park, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Extracellular vesicles: immunomodulation, diagnosis, and promising therapeutic roles for rheumatoid arthritis
Desalegn Abebaw, Yibeltal Akelew, Adane Adugna, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Desalegn Abebaw, Yibeltal Akelew, Adane Adugna, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS
Julie Joseph, Grace Sandel, Ratuja Kulkarni, et al.
Pathogens (2023) Vol. 13, Iss. 1, pp. 14-14
Open Access
Julie Joseph, Grace Sandel, Ratuja Kulkarni, et al.
Pathogens (2023) Vol. 13, Iss. 1, pp. 14-14
Open Access